Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients
Clinical trial NCT05014607 · AVAILABLE
Trial details
- NCT number
- NCT05014607
- Sponsor
- University Hospital Tuebingen
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.